Literature DB >> 6304239

A comparison of the terminal protein and hexon polypeptides of avian and human adenoviruses.

P Li, A J Bellett, C R Parish.   

Abstract

It was found that the virion terminal protein of chick embryo lethal orphan (CELO) virus had a molecular weight of 46,000, and the hexon a molecular weight of 100,000. 125I-labelled tryptic and chymotryptic peptide maps of the hexons and terminal proteins from CELO virus and human adenovirus type 5 (Ad5) differed. However, limited proteolysis of CELO virus and Ad5 terminal proteins by protease V8 showed similarities which were not detected in the case of the two hexons.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6304239     DOI： 10.1099/0022-1317-64-6-1375

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  6 in total

1.  DNA sequence analysis of an avian adenovirus terminal protein precursor.

Authors:  R J McCoy; M Sheppard
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  The complete DNA sequence and genomic organization of the avian adenovirus CELO.

Authors:  S Chiocca; R Kurzbauer; G Schaffner; A Baker; V Mautner; M Cotten
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  Recognition of adenovirus types in faecal samples by southern hybridization in South Australia.

Authors:  L D Mickan; T W Kok
Journal:  Epidemiol Infect       Date:  1994-06       Impact factor: 2.451

4.  VA RNAs from avian and human adenoviruses: dramatic differences in length, sequence, and gene location.

Authors:  S Larsson; A Bellett; G Akusjärvi
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

5.  Structural organization and polypeptide composition of the avian adenovirus core.

Authors:  P Li; A J Bellett; C R Parish
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

6.  Transcriptional organization of the avian adenovirus CELO.

Authors:  V Payet; C Arnauld; J P Picault; A Jestin; P Langlois
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.